AnodyneWiki

Valproate

Valproate
Valproate
Molecular structure drawn from PubChem coordinates
Physical properties
[]
Molecular mass143.20 g/mol [1]
Predicted LogP3.4 [1]
Structural Identifiers
[]
Molecular formulaC8H15O2-
IUPAC name2-propylpentanoate
SMILESCCCC(CCC)C(=O)[O-]
InChIInChI=1S/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10)/p-1
InChIKeyNIJJYAXOARWZEE-UHFFFAOYSA-M
PubChem CID3549980
Pharmacokinetics[]
Elimination half-life9–16 hours
MetabolismLiver—glucuronide conjugation 30–50%; mitochondrial β-oxidation over 40%; oxidation, hydroxylation, and dehydrogenation 15–20%
ExcretionMostly via hepatic metabolism, <3% in urine
Routes of administrationOral, intravenous

Valproate (also known as 2-propylvalerate or Ccg-204971).

Chemistry

 []

Valproate is achiral.

Valproate matches Lipinski's rule of five.

Pharmacology

Medical side effects []

302 side effects listed on drug labels in (valproate).

  • Headache
  • Nausea
  • Asthenia
  • Fatigue
  • Tremor
  • Somnolence
  • Drowsiness
  • Diplopia
  • Vomiting
  • Infection
  • Diarrhoea
  • Dizziness
  • Thrombocytopenia
  • Influenza
  • Insomnia
  • Decreased appetite
  • Pain
  • Dyspepsia
  • Abdominal pain
  • Abdominal cramps
  • Gastrointestinal pain
  • Nervousness
  • Tension
  • Amblyopia
  • Ataxia
  • Back pain
  • Vision blurred
  • Alopecia
  • Nystagmus
  • Coagulopathy
  • Dermatitis
  • Rash
  • Body temperature increased
  • Pharyngitis
  • Weight decreased
  • Mood swings
  • Affect lability
  • Injury
  • Increased appetite
  • Thinking abnormal
  • Mental disability
  • Oedema peripheral
  • Muscle twitching
  • Amnesia
  • Bronchitis
  • Constipation
  • Rhinitis
  • Sleep disorder
  • Influenza like illness
  • Depression
  • Ecchymosis
  • Spontaneous bruising
  • Endocrine disorder
  • Metabolic disorder
  • Tinnitus
  • Weight increased
  • Paraesthesia
  • Dyspnoea
  • Neonatal disorder
  • Drug interaction
  • Pharmacokinetic interaction
  • Aggression
  • Agranulocytosis
  • Anaphylactic shock
  • Anaemia
  • Aplastic anaemia
  • Autism
  • Enuresis
  • Eosinophilia
  • Toxic epidermal necrolysis
  • Erythema multiforme
  • Stevens-Johnson syndrome
  • Folate deficiency
  • Multiple fractures
  • Fracture
  • Hostility
  • Hypersensitivity
  • Hyponatraemia
  • Inappropriate antidiuretic hormone secretion
  • Leukopenia
  • Lymphocytosis
  • Osteopenia
  • Osteoporosis
  • Pancytopenia
  • Bone marrow depression
  • Polycystic ovaries
  • Psychotic disorder
  • Swelling
  • Urinary tract infection
  • Bone pain
  • Menstruation irregular
  • Porphyria acute
  • Amenorrhoea
  • Galactorrhoea
  • Cutaneous vasculitis
  • Photosensitivity reaction
  • Agitation
  • Excitement
  • Hyperkinesia
  • Developmental delay
  • Congenital anomaly
  • Bradycardia
  • Hypofibrinogenaemia
  • Emotional distress
  • Deafness
  • Hearing impaired
  • Autism spectrum disorder
  • Breast enlargement
  • Pancreatitis acute
  • Anaemia macrocytic
  • Angioedema
  • Anxiety
  • Arrhythmia
  • Arthralgia
  • Musculoskeletal discomfort
  • Myalgia
  • Abnormal behaviour
  • Mental disorder
  • Blister
  • Dermatitis bullous
  • Vesiculobullous rash
  • Breast disorder
  • Catatonia
  • Catatonic reaction
  • Neck pain
  • Chest pain
  • Cognitive disorder
  • Coma
  • Confusional state
  • Feeling abnormal
  • Malaise
  • Conjunctivitis
  • Connective tissue disorder
  • Contusion
  • Cystitis
  • Bladder pain
  • Cystitis noninfective
  • Cyst
  • Dysphagia
  • Drug eruption
  • Dysarthria
  • Osteoarthritis
  • Arthropathy
  • Dysgeusia
  • Dysmenorrhoea
  • Dysuria
  • Ear disorder
  • Ear pain
  • Oedema
  • Enzyme induction
  • Epistaxis
  • Eructation
  • Erythema nodosum
  • Extrapyramidal disorder
  • Eye disorder
  • Fanconi syndrome
  • Renal tubular disorder
  • Faecal incontinence
  • Flatulence
  • Furuncle
  • Gastroenteritis
  • Gastrointestinal disorder
  • Gingival bleeding
  • Glossitis
  • Hallucination
  • Atrioventricular block
  • Haematemesis
  • Haematoma
  • Haemorrhage
  • Haemoglobin
  • Hiccups
  • Hypertension
  • Hypoaesthesia
  • Hypoproteinaemia
  • Hypotension
  • Orthostatic hypotension
  • Body temperature decreased
  • Hypothermia
  • Hypothyroidism
  • Immune system disorder
  • Incontinence
  • Infertility male
  • Learning disorder
  • Muscle spasms
  • Lethargy
  • Cutaneous lupus erythematosus
  • Mediastinal disorder
  • Menstrual disorder
  • Metrorrhagia
  • Hypertonia
  • Fungal infection
  • Myelodysplastic syndrome
  • Necrosis
  • Neoplasm
  • Nervous system disorder
  • Neutropenia
  • Otitis media
  • Palpitations
  • Pancreatitis
  • Tooth abscess
  • Personality disorder
  • Petechiae
  • Pleural effusion
  • Pneumonia
  • Polyp
  • Polyuria
  • Urine output increased
  • Pruritus
  • Aplasia pure red cell
  • Seborrhoeic dermatitis
  • Sinusitis
  • Speech disorder
  • Stomatitis
  • Mouth ulceration
  • Hyperhidrosis
  • Sweating increased
  • Tachycardia
  • Tooth disorder
  • Pollakiuria
  • Urinary incontinence
  • Urethral disorder
  • Urinary tract disorder
  • Urticaria
  • Vaginal inflammation
  • Vaginal infection
  • Angiopathy
  • Vasculitis
  • Vasodilation procedure
  • Vertigo
  • Viral infection
  • Dry mouth
  • Encephalopathy
  • Chills
  • Polydipsia
  • Hepatic failure
  • Stupor
  • Depressed level of consciousness
  • CNS depression NOS
  • Photophobia
  • Hypokinesia
  • Hepatic function abnormal
  • Musculoskeletal stiffness
  • Nuchal rigidity
  • Amylase increased
  • Serum amylase increased
  • Bleeding time prolonged
  • Drug level increased
  • Injection site inflammation
  • Injection site reaction
  • Eye pain
  • Injection site pain
  • Prothrombin level increased
  • Rash pustular
  • Hyperreflexia
  • Aspartate aminotransferase increased
  • Alanine aminotransferase increased
  • Dry skin
  • Vascular anomaly
  • Increased tendency to bruise
  • Liver injury
  • Traumatic liver injury
  • Malnutrition
  • Skin disorder
  • Discomfort
  • Ill-defined disorder
  • Abdominal pain upper
  • Asterixis
  • Teratogenicity
  • Disturbance in attention
  • Memory impairment
  • Abnormal dreams
  • Euphoric mood
  • Hepatotoxicity
  • Cerebral atrophy
  • Hepatic enzyme increased
  • Parkinsonism
  • Hepatobiliary disease
  • Petit mal epilepsy
  • Coagulation factor decreased
  • Dry eye
  • Systemic lupus erythematosus
  • Rash maculo-papular
  • Liver function test normal
  • Pruritus generalised
  • Dementia
  • Coordination abnormal
  • Visual impairment
  • Abnormal vision
  • Face oedema
  • Hypovolaemia
  • Abdominal discomfort
  • Gastrointestinal tract irritation
  • Cough
  • Gait disturbance
  • Tardive dyskinesia
  • Cerebellar atrophy
  • Administration site reaction
  • Mental status changes
  • Thyroid function test abnormal
  • Muscular weakness
  • Epidermal necrosis
  • Vaginal haemorrhage

Indications

  • Acquired immunodeficiency syndrome
  • Aggression
  • Bipolar disorder
  • Bipolar I disorder
  • Complex partial seizures
  • Convulsion
  • Convulsions generalised
  • Decreased interest
  • Dehydration
  • Delusion of grandeur
  • Depressed mood
  • Disorders of urea cycle metabolism
  • Drug interaction
  • Epilepsy
  • Fasting
  • Flight of ideas
  • Hepatic enzyme increased
  • Hepatic function abnormal
  • Hostility
  • Hyperammonaemia
  • Hyperammonaemic encephalopathy
  • Hyperkinesia
  • Irritability
  • Loss of consciousness
  • Major depressive disorder, single episode
  • Mania
  • Mania acute
  • Manic episode
  • Migraine
  • Myoclonic epilepsy
  • Nonketotic hyperglycinaemia
  • Petit mal epilepsy
  • Pregnancy
  • Pressure of speech
  • Psychotic disorder
  • Somnolence
  • Status epilepticus
  • Systemic lupus erythematosus
  • Thrombocytopenia
  • Tonic-clonic seizures
  • Urinary tract infection

 []

  • Australia: Valproate is a Schedule 4.
  • Brazil: Valproate is a C1.[2]
  • Canada: Valproate is Prescription only.[3]
  • United Kingdom: Valproate is Prescription only.
  • United States: Valproate is Prescription only.

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 3549980, Valproate. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/3549980
  2. RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992
  3. Product monograph brand safety updates. Health Canada. 7 July 2016. https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database/label-safety-assessment-update/product-monograph-brand-safety-updates.html

Data sources []

SourceStatusUpdated (UTC)
dosingmissing (no dosing statistics)2026-11-20 07:53:31
drugspromissing (no DrugsPRO reagent data)2026-11-20 07:53:27
erowidmissing (no Erowid substance of that name)2026-11-20 07:53:27
gsrsmissing (no UNII)2026-11-20 07:53:27
hmdbmissing (no HMDB id)2026-11-20 07:53:27
keggmissing (no KEGG DRUG entry)2026-11-20 07:53:30
pubchemok2026-11-20 07:53:27
redditmissing (no r/tripreports posts mention it)2026-11-20 07:53:27
siderok2026-11-20 07:53:28
structureok2026-11-20 07:53:27
wikipediaok2026-11-20 07:53:27